BACKGROUND: Radiation exposure, especially in childhood, is known to increase the risk for the development of thyroid cancer. However, the prognosis of patients with thyroid cancer with a history of radiation treatment exposure remains unclear. METHODS: One hundred and sixteen patients with a previous history of radiotherapy in the head and neck region were identified from an institutional database of 3664 patients with differentiated thyroid cancer treated between 1986 and 2010. Using the Kaplan-Meier method, disease-specific survival and recurrence-free survival were compared between patients with (RT; n = 116) and without (No RT; n = 3509) a prior history of radiation exposure. RESULTS: The median ages of the RT and No RT cohorts were 52 and 47 years. The median follow-up for both groups was 54 months. Patients who had a prior history of radiation treatment exposure were more likely to be male (38.8% vs. 26.9%; p = 0.005) and older than 45 years of age (67.2% vs. 53.9%; p = 0.005). Other patient, tumor, and treatment characteristics were similar between the groups. There was no difference in the five-year disease-specific survival of the RT and No RT patients (97.4% vs. 98.7%; p = 0.798). The five-year recurrence-free survival was also similar between the RT and No RT patients (97.8% vs. 94.9%; p = 0.371). CONCLUSION: The findings suggest that differentiated thyroid cancer patients with a history of prior radiation treatment exposure have similar outcomes to those with no history of head and neck radiation exposure.
BACKGROUND: Radiation exposure, especially in childhood, is known to increase the risk for the development of thyroid cancer. However, the prognosis of patients with thyroid cancer with a history of radiation treatment exposure remains unclear. METHODS: One hundred and sixteen patients with a previous history of radiotherapy in the head and neck region were identified from an institutional database of 3664 patients with differentiated thyroid cancer treated between 1986 and 2010. Using the Kaplan-Meier method, disease-specific survival and recurrence-free survival were compared between patients with (RT; n = 116) and without (No RT; n = 3509) a prior history of radiation exposure. RESULTS: The median ages of the RT and No RT cohorts were 52 and 47 years. The median follow-up for both groups was 54 months. Patients who had a prior history of radiation treatment exposure were more likely to be male (38.8% vs. 26.9%; p = 0.005) and older than 45 years of age (67.2% vs. 53.9%; p = 0.005). Other patient, tumor, and treatment characteristics were similar between the groups. There was no difference in the five-year disease-specific survival of the RT and No RT patients (97.4% vs. 98.7%; p = 0.798). The five-year recurrence-free survival was also similar between the RT and No RT patients (97.8% vs. 94.9%; p = 0.371). CONCLUSION: The findings suggest that differentiated thyroid cancerpatients with a history of prior radiation treatment exposure have similar outcomes to those with no history of head and neck radiation exposure.
Entities:
Keywords:
outcomes; radiation exposure; radiotherapy; thyroid cancer
Authors: M D Tronko; T I Bogdanova; I V Komissarenko; O V Epstein; V Oliynyk; A Kovalenko; I A Likhtarev; I Kairo; S B Peters; V A LiVolsi Journal: Cancer Date: 1999-07-01 Impact factor: 6.860
Authors: M Santoro; F Carlomagno; I D Hay; M A Herrmann; M Grieco; R Melillo; M A Pierotti; I Bongarzone; G Della Porta; N Berger Journal: J Clin Invest Date: 1992-05 Impact factor: 14.808
Authors: Pavel O Rumyantsev; Vladimir A Saenko; Alexey A Ilyin; Valery F Stepanenko; Ulyana V Rumyantseva; Aleksandr Yu Abrosimov; Evgeny F Lushnikov; Tatiana I Rogounovitch; Yoshisada Shibata; Norisato Mitsutake; Anatoly F Tsyb; Shunichi Yamashita Journal: J Clin Endocrinol Metab Date: 2010-11-17 Impact factor: 5.958
Authors: F Pacini; T Vorontsova; E P Demidchik; E Molinaro; L Agate; C Romei; E Shavrova; E D Cherstvoy; Y Ivashkevitch; E Kuchinskaya; M Schlumberger; G Ronga; M Filesi; A Pinchera Journal: J Clin Endocrinol Metab Date: 1997-11 Impact factor: 5.958
Authors: A W Furmanchuk; J I Averkin; B Egloff; C Ruchti; T Abelin; W Schäppi; E A Korotkevich Journal: Histopathology Date: 1992-11 Impact factor: 5.087
Authors: Yuri E Demidchik; Eugene P Demidchik; Christoph Reiners; Johannes Biko; Mariko Mine; Vladimir A Saenko; Shunichi Yamashita Journal: Ann Surg Date: 2006-04 Impact factor: 12.969
Authors: Cristina Martucci; Alessandro Crocoli; Maria Debora De Pasquale; Claudio Spinelli; Silvia Strambi; Paolo Brazzarola; Eleonora Morelli; Jessica Cassiani; Juliana Mancera; Juan Pablo Luengas; Pablo Lobos; Daniel Liberto; Estefanìa Astori; Sabine Sarnacki; Vincent Couloigner; François Simon; Cassandre Lambert; Simone de Campos Vieira Abib; Onivaldo Cervantes; Eliana Caran; Diana Delgado Lindman; Matthew O Jones; Rajeev Shukla; Paul D Losty; Alessandro Inserra Journal: Front Pediatr Date: 2022-07-22 Impact factor: 3.569